Rifaximin‐altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials-Reference-Cited by-同舟云学术

Rifaximin‐altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials

Published:2019-02 Issue:4 Volume:49 Page:404-418
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Kawaguchi Takumi¹^ORCID,Suzuki Fumitaka²,Imamura Masatoshi³,Murashima Naoya⁴,Yanase Mikio⁵,Mine Tetsuya⁶,Fujisawa Masaki⁷,Sato Ikuya⁷,Yoshiji Hitoshi⁸,Okita Kiwamu⁹,Suzuki Kazuyuki¹⁰

Affiliation:

1. Division of Gastroenterology, Department of MedicineKurume University School of Medicine Kurume Japan

2. Department of HepatologyToranomon Hospital Tokyo Japan

3. Departments of Gastroenterology and HepatologyKohnodai Hospital Ichikawa Japan

4. Department of GastroenterologyMishuku Hospital Tokyo Japan

5. GastroenterologyNational Center for Global Health and Medicine Tokyo Japan

6. Department of GastroenterologyTokai University Hospital Isehara Japan

7. Development DivisionASKA Pharmaceutical Co., Ltd Tokyo Japan

8. Third Department of Internal MedicineNara Medical University Kashihara Japan

9. Shunan Memorial Hospital Kudamatsu Japan

10. Division of Hepatology, Department of Internal MedicineIwate Medical University Morioka Japan

Funder